| Quarterly Financials | Mar 2016 | Jun 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 |
Revenue  | 0 | 0 | 3 | 12 | 6 | 5 | 0 | 6 | 15 | 17 | 17 | 9 | 7 | 10 |
| Expenses | 0 | 0 | 2 | 11 | 6 | 5 | 1 | 5 | 15 | 17 | 17 | 9 | 6 | 10 |
| EBITDA | 0 | -0 | 1 | 1 | 0 | 0 | -0 | 1 | 0 | 0 | -1 | 0 | 0 | 0 |
| Operating Profit % | 0 % | 0 % | 26 % | 7 % | 1 % | 1 % | -50 % | 7 % | 2 % | 1 % | -5 % | 2 % | 3 % | 0 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | -0 | 1 | 1 | -0 | -0 | -0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | -0 | 1 | 1 | -0 | -0 | -0 | 0 | 0 | 0 | -1 | 0 | 0 | 0 |
| EPS in ₹ | 0.00 | -0.53 | 0.90 | 1.12 | -0.23 | -0.19 | -0.70 | 0.62 | 0.46 | 0.24 | -1.21 | 0.21 | 0.15 | -0.07 |
Prism Medico & Pharmacy
Prism Medico & Pharmacy
31.99
+0.93
(2.99%)
Market Cap
19.36 Cr
PE Ratio
31.37
Volume
15,644.00
Day High - Low
32.00 - 29.51
52W High-Low
33.58 - 12.49
There are new updates from the company1 day ago
View
Key Fundamentals
Market Cap
19.36 Cr
EPS
0.07
PE Ratio
31.37
PB Ratio
1.25
Book Value
24.89
EBITDA
0.40
Dividend Yield
0.00 %
Industry
Financial Services Sector
NBFC Return on Equity
0.31
Debt to Equity
0.17
Actual
Company News
View All News
Prism Medico and Pharmacy Limited submitted confirmation certificate under SEBI regulations for Q4FY26 ended March 31, 2026, with no share dematerialization activity during the quarter.
Prism Medico and Pharmacy Limited disclosed that promoters made no share encumbrances during FY26, complying with SEBI regulations for substantial acquisition disclosures.
Prism Medico and Pharmacy Limited confirms it has not issued any non-convertible securities and had no interest, dividend, or principal payment obligations during Q4FY26 under SEBI LODR regulations.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
934.75 | #1 5,81,646.49 | 31.92 | #1 69,724.80 | 26.81 | #1 16,780 | -5.62 | 57.34 | |
1,044.55 | 1,96,538.91 | 26.89 | 41,859.50 | 19.61 | 9,423 | -22.13 | 58.05 | |
238.51 | 1,51,528.78 | 95.37 | 3,513.26 | 69.00 | 1,606 | -13.89 | 48.67 | |
3,586.90 | 1,44,002.73 | 16.75 | 20,324.50 | 34.04 | 5,352 | 102.90 | 57.76 | |
1,565.60 | 1,33,365.58 | 27.93 | 26,152.80 | 34.67 | 4,260 | 18.54 | 53.57 | |
686.20 | 65,298.43 | 30.92 | 18,637.10 | 6.60 | 1,916 | 45.25 | 49.63 | |
4,902.10 | 54,464.22 | 26.85 | 8,563.00 | 17.53 | 1,813 | 18.86 | 49.08 | |
300.25 | 41,733.88 | 17.92 | 18,530.50 | 16.03 | 2,261 | -10.03 | 44.00 | |
484.80 | 41,170.45 | #1 11.01 | 4,612.20 | #1 76.63 | 4,241 | -70.06 | 56.66 | |
424.10 | 34,470.37 | 106.41 | 4,222.80 | 34.17 | -98 | #1 703.21 | 56.29 |
Growth Rate
Revenue Growth
139.91 %
Net Income Growth
-
Cash Flow Change
-112.39 %
ROE
-1,133.33 %
ROCE
-97.09 %
EBITDA Margin (Avg.)
-79.55 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2017 | 2018 | 2019 |
| Total Assets | 17 | 16 | 21 |
| Fixed Assets | 10 | 9 | 9 |
| Current Assets | 7 | 4 | 11 |
| Capital Work in Progress | 0 | 0 | 0 |
| Investments | 0 | 3 | 1 |
| Other Assets | 7 | 4 | 11 |
| Total Equity & Liabilities | 17 | 16 | 21 |
| Current Liabilities | 1 | 3 | 8 |
| Non Current Liabilities | 3 | 0 | 0 |
| Total Equity | 13 | 13 | 13 |
| Reserve & Surplus | 7 | 7 | 7 |
| Share Capital | 6 | 6 | 6 |
Cash Flow
| Cash Flow | 2017 | 2018 | 2019 |
| Net Cash Flow | 0 | -1 | -1 |
| Investing Activities | 0 | -3 | 0 |
| Operating Activities | 0 | 4 | -0 |
| Financing Activities | 0 | -2 | -1 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 |
| Promoter | 38.02 % | 29.06 % | 23.93 % | 23.93 % | 23.93 % | 23.93 % | 23.93 % | 23.93 % | 23.93 % | 25.00 % | 25.00 % | 25.00 % | 25.00 % | 25.00 % | 25.00 % | 25.00 % | 25.00 % | 25.00 % | 25.00 % | 25.00 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 54.60 % | 59.85 % | 69.11 % | 68.82 % | 67.22 % | 67.65 % | 64.91 % | 64.89 % | 61.78 % | 63.66 % | 64.02 % | 65.76 % | 67.23 % | 67.30 % | 65.77 % | 65.36 % | 66.07 % | 65.26 % | 65.26 % | 65.63 % |
| Others | 7.38 % | 11.09 % | 6.95 % | 7.25 % | 8.85 % | 8.42 % | 11.16 % | 11.18 % | 14.29 % | 11.34 % | 10.98 % | 9.24 % | 7.77 % | 7.70 % | 9.23 % | 9.64 % | 8.93 % | 9.74 % | 9.74 % | 9.37 % |
| No of Share Holders | 1,243 | 1,900 | 2,790 | 3,731 | 4,245 | 4,168 | 3,890 | 3,328 | 3,558 | 3,610 | 3,465 | 3,650 | 3,792 | 3,866 | 4,107 | 4,178 | 4,302 | 4,306 | 4,315 | 4,306 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 30 May 2018 |  Change Of Name | NA | 30 May 2018 | 25.50 | 25.50 |
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 34.88 | 29.91 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 26.51 | 27.05 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 17.28 | 16.68 |
| 28 May 2025 | Quarterly Result Announcement | NA | 28 May 2025 | 14.68 | 16.65 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 13.75 | 13.84 |
| 30 Sept 2025 | Annual General Meeting | NA | 30 Sept 2025 | 17.85 | 21.43 |
| 14 Nov 2025 | Quarterly Result Announcement | NA | 14 Nov 2025 | 19.07 | 19.43 |
| 13 Feb 2026 | Quarterly Result Announcement | NA | 13 Feb 2026 | 18.45 | 17.10 |
| 20 Mar 2026 |  Extraordinary General Meeting | NA | 20 Mar 2026 | 22.58 | 25.54 |
Announcements
Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.
1 day ago
1 day agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 20189 days ago
9 days agoCompliance-57 (5) : intimation after the end of quarterApr 07, 2026
Apr 07, 2026Disclosures Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 For The Financial Year Ended 31St March 2026.Apr 07, 2026
Apr 07, 2026Compliance-57 (5) : intimation after the end of quarterApr 06, 2026
Apr 06, 2026Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Mar 30, 2026
Mar 30, 2026Closure of Trading WindowMar 30, 2026
Mar 30, 2026Clarification With Respect To Significant Movement In The Price Of Our Security At The Stock Exchange.Mar 30, 2026
Mar 30, 2026Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMar 24, 2026
Mar 24, 2026Regulation 30(2) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - Proceedings Of Extraordinary General Meeting Held On 20Th March 2026.Mar 20, 2026
Mar 20, 2026Shareholder Meeting / Postal Ballot-Outcome of EGMMar 20, 2026
Mar 20, 2026Publication Of Corrigendum To Notice To Shareholders.Mar 19, 2026
Mar 19, 2026Intimation Regarding Record Date.Feb 26, 2026
Feb 26, 2026Intimation Of Book Closure.Feb 26, 2026
Feb 26, 2026Notice Of Extraordinary General Meeting.Feb 25, 2026
Feb 25, 2026Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 23, 2026
Feb 23, 2026Clarification sought from Prism Medico and Pharmacy LtdFeb 23, 2026
Feb 23, 2026Board Meeting Intimation for Intimation Of Board Meeting.Feb 18, 2026
Feb 18, 2026Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Feb 13, 2026
Feb 13, 2026Board Meeting Intimation for Consideration Approval And Taking On Record The Unaudited Standalone Financial Results Of The Company Along With The Limited Review Report For The Quarter Ended 31St December 2025.Feb 07, 2026
Feb 07, 2026Undertaking Of Functional WebsiteJan 30, 2026
Jan 30, 2026Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Jan 16, 2026
Jan 16, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 14, 2026
Jan 14, 2026Compliance-57 (5) : intimation after the end of quarterJan 02, 2026
Jan 02, 2026Intimation Under Regulation 57(4) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Dec 31, 2025
Dec 31, 2025Closure of Trading WindowDec 24, 2025
Dec 24, 2025Revised Outcome Of The Board Meeting Held On 14Th November 2025.Nov 21, 2025
Nov 21, 2025Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Nov 14, 2025
Nov 14, 2025Board Meeting Intimation for Intimation Of Board Meeting.Nov 06, 2025
Nov 06, 2025Undertaking Of Functional Website.Oct 27, 2025
Oct 27, 2025Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.Oct 17, 2025
Oct 17, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 13, 2025
Oct 13, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Oct 01, 2025Compliance-57 (5) : intimation after the end of quarterOct 01, 2025
Oct 01, 2025Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Oct 01, 2025
Oct 01, 2025Closure of Trading WindowOct 01, 2025
Oct 01, 2025Regulation 30(2) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - Proceedings Of 23Rd Annual General Meeting Held On 30Th September 2025.Sep 30, 2025
Sep 30, 2025Outcome Of 23Rd Annual General Meeting Held On 30Th September 2025 At 11:30 A.M. Through Video Conferencing/Other Audio Visual Means.Sep 30, 2025
Sep 30, 2025Revised Outcome Of Board Meeting Dated 14Th August 2025.Sep 12, 2025
Sep 12, 2025Reg. 34 (1) Annual Report.Sep 06, 2025
Sep 06, 2025Intimation Of Record Date.Sep 05, 2025
Sep 05, 2025Intimation Of Book Closure.Sep 05, 2025
Sep 05, 2025Notice Of 23Rd Annual General Meeting.Sep 05, 2025
Sep 05, 2025Annual Report For The Financial Year 2024-2025.Sep 05, 2025
Sep 05, 2025Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Sep 05, 2025
Sep 05, 2025Board Meeting Intimation for Intimation Of Board Meeting.Sep 01, 2025
Sep 01, 2025Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 14, 2025
Aug 14, 2025Announcement under Regulation 30 (LODR)-Meeting UpdatesAug 07, 2025
Aug 07, 2025Board Meeting Intimation for Meeting To Be Held On Thursday The 14Th Day Of August 2025 At 01:30 P.M. At The Registered Office Of The Company I.E. Suketi Road Kala Amb Sirmaur Himachal Pradesh-173030.Aug 07, 2025
Aug 07, 2025Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 04, 2025
Aug 04, 2025Technical Indicators
RSI(14)
Neutral 65.62
ATR(14)
Volatile 2.36
STOCH(9,6)
Overbought 80.18
STOCH RSI(14)
Overbought 90.23
MACD(12,26)
Bullish 0.33
ADX(14)
Strong Trend 28.37
UO(9)
Bearish 62.66
ROC(12)
Uptrend And Accelerating 17.74
WillR(14)
Neutral -26.69
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
